ANDRE
ALBINATI,
Earnscliffe Strategy Group
(Consultant)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Celine Caira,
Senior Policy Advisor
| Office of the Minister of Innovation, Science and Industry
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry
Communication date:
2021-01-11
Posted date:
2021-02-15
Communication number:
2182-494329
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Kathryn Nowers,
Director of Policy
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2020-10-15
Posted date:
2020-11-16
Communication number:
2182-488240
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Celine Caira,
Policy Advisor
| Office of the Minister of Innovation, Science and Industry
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Intellectual Property,
Science and Technology,
Research and Development
Communication date:
2020-04-21
Posted date:
2020-05-15
Communication number:
2182-473717
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Taras Zalusky,
Acting Chief of Staff
| Office of the Minister of Public Services and Procurement and Accessibility
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Health,
Industry,
International Trade,
Research and Development
Communication date:
2019-07-30
Posted date:
2019-08-15
Communication number:
2182-458913
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Jason Easton,
Chief of Staff
| Office of the Minister of Small Business and Export Promotion
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
International Trade,
Research and Development
Communication date:
2019-07-30
Posted date:
2019-08-15
Communication number:
2182-458912
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Rick Theis,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry
Communication date:
2019-06-25
Posted date:
2019-07-15
Communication number:
2182-456759
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Amanda Woodley,
Policy Advisor
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
Research and Development
Communication date:
2019-06-03
Posted date:
2019-07-15
Communication number:
2182-456786
(amended from
2182-456758)
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Amanda Woodley,
Policy Advisor
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
Research and Development
Communication date:
2019-06-03
Posted date:
2019-07-15
Communication number:
2182-454942
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Gianluca Cairo,
Chief of Staff
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
Research and Development
Communication date:
2019-05-29
Posted date:
2019-06-15
Communication number:
2182-454183
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Jamie Innes,
Director of Policy and Issues Management
| Office of the Minister of International Trade
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health,
Industry,
International Trade,
Research and Development
Communication date:
2019-05-24
Posted date:
2019-06-15
Communication number:
2182-454943
(amended from
2182-454181)
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Taras Zalusky,
Director of Policy for Procurement and Parliamentary Affairs
| Office of the Minister
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Health,
Industry
Communication date:
2019-04-23
Posted date:
2019-05-15
Communication number:
2182-451829
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Taras Zalusky,
Director of Policy for Procurement and Parliamentary Affairs
| Office of the Minister
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Health,
Industry
Communication date:
2019-04-12
Posted date:
2019-05-15
Communication number:
2182-451825
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Matt Stickney,
Chief of Staff
| Office of the Minister
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Health,
Industry
Communication date:
2019-04-11
Posted date:
2019-05-15
Communication number:
2182-451823
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Gianluca Cairo,
Chief of Staff
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Science and Technology,
Research and Development
Communication date:
2019-01-18
Posted date:
2019-02-15
Communication number:
2182-445045
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Hilary Travis,
Policy Advisor
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Science and Technology,
Research and Development
Communication date:
2019-01-11
Posted date:
2019-02-15
Communication number:
2182-445052
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Hilary Travis,
Policy Advisor
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Science and Technology,
Research and Development
Communication date:
2019-01-11
Posted date:
2019-02-15
Communication number:
2182-443816
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Hilary Travis,
Policy Advisor
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Industry,
Science and Technology,
Research and Development
Communication date:
2018-11-15
Posted date:
2018-12-15
Communication number:
2182-440742
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Rick Theis,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry
Communication date:
2018-08-17
Posted date:
2018-09-15
Communication number:
2182-433785
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Rick Theis,
Policy Advisor
|
Prime Minister's Office (PMO)
-
Rick Theis,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2018-06-01
Posted date:
2018-07-16
Communication number:
2182-431225
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Hilary Travis,
Special Assistant (Policy)
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development
Communication date:
2018-04-17
Posted date:
2018-05-15
Communication number:
2182-426348
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Genevieve Hinse,
Chief of Staff
| Office of the Minister
|
Health Canada (HC)
-
Kathryn Nowers,
Director of Policy
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology,
Research and Development
Communication date:
2018-03-28
Posted date:
2018-04-16
Communication number:
2182-424371
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Maxime Dea,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry,
Regional Development,
Science and Technology
Communication date:
2017-11-02
Posted date:
2017-12-15
Communication number:
2182-415310
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Tyler Meredith,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2017-09-07
Posted date:
2017-10-16
Communication number:
2182-409063
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Robert Asselin,
Director of Policy and Budget Director
| Office of the Minister
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2017-08-17
Posted date:
2017-09-15
Communication number:
2182-407975
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Tyler Meredith,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2017-05-17
Posted date:
2017-06-15
Communication number:
2182-403098
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Tyler Meredith,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2017-04-05
Posted date:
2017-05-15
Communication number:
2182-400582
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Tyler Meredith,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2016-10-11
Posted date:
2016-11-15
Communication number:
2182-386738
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Robert Asselin,
Director of Policy
|
Finance Canada (FIN)
Subject Matter of the communication:
International Trade
Communication date:
2016-07-29
Posted date:
2016-08-15
Communication number:
2182-382339
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Justin To,
Policy Advisor (Economic and Innovation)
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Intellectual Property
Communication date:
2016-07-26
Posted date:
2016-08-15
Communication number:
2182-382338
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Scott Tessier,
Chief of Staff
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2010-10-06
Posted date:
2010-11-16
Communication number:
2182-159420
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Karen Dodds,
Assistant Deputy Minister
| Office of the Assistant Deputy Minister
|
Health Canada (HC)
-
Ron Parker,
Senior Assistant Deputy Minister
| Industry Sector
|
Industry Canada
Subject Matter of the communication:
Health,
Industry
Communication date:
2010-05-31
Posted date:
2010-06-16
Communication number:
2182-149616
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Scott Tessier,
Chief of Staff
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2010-01-06
Posted date:
2010-02-16
Communication number:
2182-138096
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Scott Tessier,
Chief of Staff
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2009-12-22
Posted date:
2010-01-06
Communication number:
2182-134678
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Don Stephenson,
Assistant Deputy Minister
| Trade Policy and Negotiations
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
Intellectual Property
Communication date:
2009-11-10
Posted date:
2009-12-15
Communication number:
2182-132819
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Philip Welford,
Chief of Staff
| Minister's Office
|
Minister of State (Science & Technology)
Subject Matter of the communication:
Science and Technology
Communication date:
2009-03-06
Posted date:
2009-04-15
Communication number:
2182-101134
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Benoit Violette,
Senior Policy Advisor
| Minister's Office
|
Industry Canada
Subject Matter of the communication:
Intellectual Property,
Science and Technology
Communication date:
2009-01-23
Posted date:
2009-02-13
Communication number:
2182-93794
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Leah Canning,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
-
Laurie Throness,
Senior Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Intellectual Property
Communication date:
2009-01-06
Posted date:
2009-02-13
Communication number:
2182-93786
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Scott Tessier,
Chief of Staff
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-12-22
Posted date:
2010-01-06
Communication number:
2182-134594
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Phillip Welford,
Chief of Staff
| Minister's Office, Minister of State (Science & Technology)
|
Industry Canada
Subject Matter of the communication:
Science and Technology
Communication date:
2008-11-20
Posted date:
2008-12-16
Communication number:
2182-88142
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
Kera Wilkinson,
Special Assistant
| Office of the Chief Government Whip
|
Chief Government Whip
Subject Matter of the communication:
Health
Communication date:
2008-07-31
Posted date:
2008-08-16
Communication number:
2182-76835
View associated registration
-
Innovative Medicines Canada
Consultant:
ANDRE ALBINATI
Designated Public Office Holders who participated in the communication:
-
David Pierce,
Special Assistant
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-07-02
Posted date:
2008-08-16
Communication number:
2182-76834
View associated registration